S21-253 Recombinant viruses that replicate in response to specific biochemical signals Engineered viruses have great potential as cancer treatments. However, the only currently approved viral therapy, T-vec (Talimogene laherparepvec), suffers from off-target effects that limit its use to intratumoral injection. Michael Lin Xinzhi Zou Hokyung Chung